MENU
TNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tango Therapeutics (TNGX) Ownership - Who owns Tango Therapeutics?

Tango Therapeutics Inc is a biotechnology company... Show more

Profile

Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.67B
P/E Ratio
N/A
Total Cash
152.81M
Projected Growth
N/A
Total Debt
34.76M
Revenue
66.5M
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash/Share
1.13
Total Debt/Equity
N/A
Revenue/Share
0.60 USD as % of share price

Fundamentals

TNGX
Capitalization
1.67B
P/E Ratio
N/A
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash
153M
Total Cash/Share
1.13
Total Debt
34.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.60%
Revenue
66.5M
ROE
N/A
Book Value
160M
P/B Ratio
10.42
Cash Flow
N/A
Earnings
-0.91
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
112K
Current Ratio
8.88
Current Revenue Per Employee
347167.75
Dividends Per Share - Security
N/A
EBITDA
-107.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.74
Shares Held By Institutions
1.35B
Shares Outstanding - Current
135M
Total Liabilities
50.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
39.842
View a ticker or compare two or three
TNGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TNGX showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com